Industry: Biotechnology Founders, Chairman &M.D: Kiran

Mazumdar Shaw Founded:1978 Headquarters: Bangalore Employees:6000(approx)

SHAREHOLDERS PERCENTAGE

Employees Trust 13%

Promoters 65%

Public 22%

1978:-Indian’s #1 Biotech company with a global biotech ranking of 16

1979:-Global leadership in specialty enzymes

1989:-Globally unique fermentation profile

1994:-SYNGENE-India’s first research company

2003:- India’s first and largest Antibody Facility-Clinigene

Revenue:-240 million US$(2011-12) Profit:-39 million US$(2011-12) Traded as BIOCON in NSE Face Value: Rs 5 Market Cap:-9222 crore EPS:- Rs. 15.43 P/E Ratio:29.83

Biotechnology has transformed many parts of the chemical industry, agriculture and medicine.

The consumption of biotech products in India was expected to quadruple within a decade.

The human and animal segment of the industry alone was growing by at least 20%.

From 2009, Indian Biotech Industry contributes to 3.5% of the global biotech industry.

In India 800 Companies were operating in all sectors of biotechnology, but only 25 were working in the modern biotech sectors.

Government is implementing a national Biotechnology Development Strategy (NBDS) and establishing a national Biotechnology Regulatory Authority (NBRA) .

100% FDI in biotechnology sector.

Special tax benefits.

THANK YOU